PharmaCyte Biotech Inc (PMCB)

[DragonBear]

So here’s your choices

Believes whats ewe wants. Butt, since another post just claimed #3, can I have #4?

4. Whatever you do, do NOT research:

The Loeb ad hoc study from 1999, and then compare to current treatments, and results. What did the control arm of Metronomic Ifosfamide without CIAB yield (Hint: there was no such control arm).

The molecular biology, and structure of a pancreatic tumor.

What's the criteria for removing it.

Chemo resistance in PC, and how it occurs. Whether metronomic dose or high dose chemo encourages chemo resistance.

The likely state of a patient's immune system, and response to chemo in PC when initially diagnosed, and 1 yr later after failing front line therapy.

What targeted pathway drugs are on the market, and which ones are in Phase 2-3 CTs for PC.

What early stage immuno therapy potential cures are appearing.

The success or not of Metronomic alkylating drugs as a monotherapy for solid tumors.

Nope don't need any of that damn research. It just gets in the way of reality! Instead read PRs since 2011. Paid consultants, and other paid 3rd parties saying the Kenny wonder treatment is wonderful. And it's coming "soon" - Q3 2015, EOY 2016, Q1 2018. Do NOT ask why: If this is a wonder treatment some large pharma didn't license it back in 2003, or fund Austrianova. Or buyout Gunzburg&Salmon's Austrianova during their BK filing. Or failing all that large pharma didn't roll their own CIAB. Do NOT look at the 10K, and wonder with a bloated O/S of 1B+ shares, what accrued value SHs have from it the past decade. Do NOT research (there's that nasty word again) what Phase 1, 2, 3 CTs cost after looking at the 10K or latest 10Q. Pretend that it costs nothing. Or some large pharma is going to pay $Bs up front for something unproven.

Yep just gotta believes in a 8 yr pile of Kenny PR pumps.